Latest California Healthline Stories
Desperate For Coverage: Are Short-Term Plans Better Than None At All?
As stopgap health plans gain attention as possible alternatives to Obamacare, consumers are advised to read the fine print.
Health Risks To Farmworkers Increase As Workforce Ages
Harvesting U.S. crops has been left to an aging population of farmworkers whose health has suffered from decades of hard labor. Older workers have a greater chance of getting injured and of developing chronic illnesses.
Churning, Confusion And Disruption — The Dark Side Of Marketplace Coverage
The Affordable Care Act has increased the number of people with insurance, but shopping around for plans puts a burden on patients, especially this year.
Pace Of U.S. Health Spending Slows In 2016
Dramatic increases in spending that came with the influx of newly insured consumers in 2014 and 2015 appear to be moderating.
If Your Insurer Covers Few Therapists, Is That Really Mental Health Parity?
Behavioral care was at least four times more likely to be out-of-network than medical or surgical care, an analysis by Milliman shows.
Facebook Live: A Status Check On Obamacare Enrollment
In this chat, KHN’s Julie Appleby offers a progress report on the 2018 sign up season.
CVS-Aetna Merger A Bid To Bring Down Costs, Gain Competitive Edge
What will the mega-merger mean for consumers and the health care industry? Senior correspondent Chad Terhune offers insight.
Middle-Class Earners Weigh Love And Money To Curb Obamacare Premiums
Ineligible for subsidies, a Tennessee woman quit her job to get an affordable health care premium. Conventional steps — such as maxing out your 401(k) contribution each year — may also do the job, financial planners say.
Congress Isn’t Really Done With Health Care — Just Look At What’s In The Tax Bills
Even though congressional Republicans set aside their Obamacare repeal-and-replace efforts this year, here are five major health policy changes that could become law as part of the pending House and Senate proposals.
Patients With Rare Diseases And Congress Square Off Over Orphan Drug Tax Credits
The House and Senate want to reduce or eliminate federal tax credits for “orphan drugs” used to treat rare diseases, but patients are fighting against the plan.